Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
From recent filing..
Remarks:
As of September 18, 2023, Symetryx Corporation does not own any shares of Common Stock of NeuBase Therapeutics, Inc
Yep ! Nice to meet you.
im retired pd and used to have a …
..
cb radio, so, i get it, lol
I haul heavy equipment... drilling rigs , trackhoes freshwater and drilling mud for a horizontal drilling company. Lol 10-4
10-4 as in ok trucker lingo lol 😆 I'm a truck driver.. 😁
it had a…
…
very strong eod (well, it can trade until 8pm our time) but very strong eod! bring on next week and maybe some merger news!
holy crap, look at the sudden buying and run!!
wow, someone got a great deal on that dip. i grabbed some as well. just not as low as i could have, lol
This is no brainer !!
Co has $5 bucks cash with no debt
Well known venture capital co just bought 20% from open market
It’s $5 at mim mim !!!!
Announcement coming very soon !!
I added a few more… .. :)
manipulation but next week we keep going imo.
Flippers paradise... :) (with a touch of investment.. :)
I'm in it to make a profit. (I know you are also).. :)
If I were SYMETRYX Corp, I would proceed to buy more shares… :)
Just saying
Might as well…. :)
NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder
September 08 2023 - 07:00AM
GlobeNewswire Inc.
NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”) today issued the following statement regarding the Schedule 13D filed with the U.S. Securities and Exchange Commission on August 31, 2023, by Symetryx Corporation (“Symetryx”) and their subsequent press release issued on September 6, 2023.
“The NeuBase Board of Directors (“Board”) appreciates input from its shareholders. The Board remains committed to completing its comprehensive exploration of strategic alternatives focused on maximizing shareholder value. The Board does not believe that shareholder value will be enhanced by issuing the special $1 per share dividend Symetryx requested in their press release. The Board and management will continue to seek an open and active dialogue with its shareholders, including Symetryx.”
Been a good stock to play with.. (All Good).. :)
then im glad i got back out and onto better stocks.
More shares added by Symetryx Form 4 filed
I bought in today. I did some due diligence and I like the company and it’s concepts. If I understand most everything is pre- clinical. Is there anything special that I’m missing? Other than the outside investment which made the stock pop the last few days?
For sure. It and SKYC have yet to establish a price really. Curious to see how they act once that happens.
I will take a look but I don’t like to own too many stocks. Today’s market is very deceiving
Good luck to you as well… took some ATXG. it seems to be holding $1.80 if it goes below I bounce. Easy peasy. Been trying to figure out GNVR. Grey to pink this week.
In LQR good luck
ATXG NVOS LQR CGC and WINT. Got to dig into WINT fundamentals but float is perfect and a sizable short on it. Seems like bottom. Still watching. Of course this one as I don’t think it’s done
Awesome what else are you looking at?
Gotcha. Well you nailed this one. Nice job. Sorry for being shook lil bitch… I did manage a 70% flip
Followers
|
10
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
249
|
Created
|
08/21/19
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |